AI Development

NVIDIA partners with Lilly on AI co-innovation lab for drug discovery

January 12, 2026 · Medium importance · deployment
Editorial Analysis

NVIDIA and Eli Lilly launched a joint AI lab to apply AI and robotics to pharmaceutical R&D.

At a Glance
Date
January 12, 2026
Importance
Medium 3/5
Category
deployment
Axis of Change
Deployment Expansion
Organizations
NVIDIA Eli Lilly
Models Affected
No specific model identified
Sources
  1. 01 investor.nvidia.com
Related Developments
Sep 16, 2026 · deployment

Novo Nordisk partners with Anthropic on Claude for drug discovery
Sep 16, 2026 · deployment

Google CEO outlines AI applications in health, weather and learning
Sep 10, 2026 · deployment

AI agents drive sharp rise in public-service applications and complaints